SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for MARRONE BIO INNOVATIONS INC (CIK 0001441693) — Dec 16, 2020

MARRONE BIO INNOVATIONS INC (CIK 0001441693)
Date: Dec. 16, 2020 · CIK: 0001441693 · Accession: 0000000000-20-012090

AI Filing Summary & Sentiment

File numbers found in text: 333-251284

Date
December 16, 2020
Author
Not clearly detected
Form
UPLOAD
Company
MARRONE BIO INNOVATIONS INC (CIK 0001441693)

Letter

United States securities and exchange commission logo December 16, 2020 Linda Moore General Counsel MARRONE BIO INNOVATIONS INC 1540 Drew Avenue Davis, California 95618 Re:MARRONE BIO INNOVATIONS INC Registration Statement on Form S-3 Filed December 11, 2020 File No. 333-251284 Dear Ms. Moore: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Laura Crotty at 202-551-7614 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Alfredo B. D. Silva

Show Raw Text
United States securities and exchange commission logo
December 16, 2020
Linda Moore
General Counsel
MARRONE BIO INNOVATIONS INC
1540 Drew Avenue
Davis, California 95618
Re:MARRONE BIO INNOVATIONS INC
Registration Statement on Form S-3
Filed December 11, 2020
File No. 333-251284
Dear Ms. Moore:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Laura Crotty at 202-551-7614 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Alfredo B. D. Silva